Investing.com - Merck KGaA reported on Friday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Merck KGaA announced earnings per share of €2.64 on revenue of €5.57B. Analysts polled by Investing.com anticipated EPS of €2.51 on revenue of €5.42B.
Merck KGaA shares are down 26.38% from the beginning of the year , still down 24.64% from its 52 week high of €230.80 set on Thursday, December 30, 2021. They are under-performing the EUR/USD which is down 0% year to date.
Merck KGaA follows other major Healthcare sector earnings this month
Merck KGaA's report follows an earnings missed by Spire Healthcare on Thursday, who reported EPS of €-0 on revenue of €596.2M, compared to forecasts EPS of €2.80 on revenue of €590.80M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar